KLK8 and melanoma: To directly validate knockdown efficiency, we transfected Klk8 siRNAs into YUMM3.3 mouse melanoma cells since Klk8 mRNA levels in B16-F1 cells were too low for reliable quantification (Fig. S1I, J).